Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric Uncomplicated Falciparum Malaria in Western Kenya
Phase of Trial: Phase III
Latest Information Update: 19 Apr 2017
At a glance
- Drugs Artemether/lumefantrine (Primary) ; Artesunate/pyronaridine (Primary)
- Indications Falciparum malaria
- Focus Therapeutic Use
- 13 Apr 2017 Planned End Date changed from 1 Jul 2016 to 1 Jul 2017.
- 13 Apr 2017 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2017.
- 02 Nov 2015 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.